scholarly journals Long-Term Treatment of HIV-Infected MT-4 Cells in Culture with HIV Proteinase Inhibitor RO 31-8959 Leads to Complete Cure of Infection

1994 ◽  
Vol 5 (4) ◽  
pp. 236-242 ◽  
Author(s):  
H. Nitschko ◽  
H. Lindhofer ◽  
H. Schätzl ◽  
J. Eberle ◽  
G. Deby ◽  
...  

An HIV-infected cell culture was treated with the specific HIV proteinase inhibitor Ro 31-8959 for three months to analyse the antiviral effect and possible cytotoxicity of the drug in long-term treatment. The drug was added 1 h after HIV infection with 0.002 m.o.i. and maintained for 87 days in the cell culture. There was no detectable cell death nor any evidence of HIV production in this time. Cells were proven to be initially infected, since premature drug removal led to a re-emergence of infectious HIV and cell death. However, after 87 days of treatment the drug could be removed safely and HIV was cleared demonstrably from the culture. These data suggest that long-term dosage may be advantageous to the clinical treatment of HIV infection by HIV proteinase inhibitors.

Endocrinology ◽  
2004 ◽  
Vol 145 (4) ◽  
pp. 2064-2070 ◽  
Author(s):  
Miguel Omar Velardez ◽  
Ariel Hernán Poliandri ◽  
Jimena Paula Cabilla ◽  
Cristian Carlos Armando Bodo ◽  
Leticia Inés Machiavelli ◽  
...  

2021 ◽  
Author(s):  
Kensuke Abe ◽  
Taku Obara ◽  
Satomi Kamio ◽  
Asahi Kondo ◽  
Junji Imamura ◽  
...  

Abstract BACKGROUND Tenofovir disoproxil fumarate (TDF) has a strong antiviral effect, but TDF is known to cause renal dysfunction. Therefore, we are investigating preventing renal dysfunction by replacing TDF with tenofovir alafenamide fumarate (TAF), which is known to be relatively safe to the kidneys. However, the changes in renal function under long-term use of TAF are not known. In this study, we evaluated renal function in Japanese HIV-1-positive patients switching to TAF after long-term treatment with TDF.METHODS A single-center observational study was conducted in Japanese HIV-1-positive patients. TDF was switched to TAF after at least 48 weeks of treatment so we could evaluate the long-term use of TDF. The primary endpoint was the estimated glomerular filtration rate (eGFR) at 144 weeks of TAF administration. In addition, we predicted the factors that would lead to changes in eGFR after long-term use of TAF.RESULTS Of the 125 HIV-1-positive patients who were prescribed TAF at our hospital during the study period, 70 fulfilled the study criteria. The eGFR at the time of switching from TDF to TAF was 81.4 ± 21.1 mL/min/1.73 m2. eGFR improved significantly after 12 weeks of taking TAF but significantly decreased at 96 and 144 weeks. At 144 weeks of taking TAF, the factors significantly correlated with the difference in eGFR from baseline were the difference in eGFR at 48 weeks of taking TAF and age at the start of TAF.CONCLUSIONS In this study, Japanese HIV-1-positive patients who had been taking TDF for a long period of time showed a decrease in eGFR after switching to long-term use of TAF. Japanese HIV-1-positive patients are expected to take TAF for a long time. Depending on age, laboratory values related to renal function need to be monitored carefully.


PLoS ONE ◽  
2014 ◽  
Vol 9 (4) ◽  
pp. e89639 ◽  
Author(s):  
Marlous L. Grijsen ◽  
Ferdinand W. N. M. Wit ◽  
Suzanne Jurriaans ◽  
Frank P. Kroon ◽  
Emile F. Schippers ◽  
...  

2007 ◽  
Vol 8 (2) ◽  
pp. 86-97 ◽  
Author(s):  
J.A. Vazquez ◽  
D.J. Skiest ◽  
H. Tissot-Dupont ◽  
J.L. Lennox ◽  
N. Boparai ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A115-A115 ◽  
Author(s):  
E CALVERT ◽  
L HOUGHTON ◽  
P COOPER ◽  
P WHORWELL

2004 ◽  
Vol 171 (4S) ◽  
pp. 424-424 ◽  
Author(s):  
Monica G. Ferrini ◽  
Eliane G. Valente ◽  
Jacob Rajfer ◽  
Nestor F. Gonzalez-Cadavid

2013 ◽  
Author(s):  
Christina Marel ◽  
Maree Teesson ◽  
Shane Darke ◽  
Katherine Mills ◽  
Joanne Ross ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document